GlassScriptPhysician profile
Douglas Schuerer
NPI 1922024140
$884.51
in general payments reported to CMS, 2019-2025
13 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $17.88 · 2022: $202 · 2023: $60.34 · 2024: $118 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $237.77 | 2019-2025 | Sternalock Blu System, Advantagerib |
| Kerecis Limited | $157.22 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Boston Scientific Corporation | $146.81 | 2025 | Spyglass Discover |
| Medtronic, INC. | $89.28 | 2022 | |
| Polarityte, INC. | $54.02 | 2019 | |
| Convatec INC. | $45.24 | 2023-2024 | |
| Hydrofera LLC | $30.37 | 2024 | Hydrofera Blue |
| Portola Pharmaceuticals, LLC | $27.74 | 2019 | |
| Polynovo North America LLC | $22.08 | 2025 | Novosorb Btm |
| Smith+Nephew, INC. | $21.31 | 2024 | Grafix Pl |
| Kls-Martin L.P. | $18.40 | 2024 | |
| Acell, INC. | $17.88 | 2020 | |
| Shire North American Group INC | $16.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Schuerer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.